NEW
YORK, July 19, 2023 /PRNewswire/ -- As the
largest minority shareholder1 of Taro Pharmaceutical
Industries Ltd. (NYSE: TARO), Krensavage Asset Management LLC
opposes Sun Pharmaceutical Industries Ltd.'s paltry bid to
take Taro private.
Sun, a 78.5% Taro shareholder, on May
26 offered to acquire the rest of Taro for $38 a share, valuing the company at $1.4 billion.
Sun's inadequate offer amounts to a 17% discount to the value of
Taro's tangible assets2, namely $36 a share of net cash3. If Taro
liquidated, shareholders could receive more than $45 a share.
Taro boasts more than just cash and real estate. The maker of
generic creams and ointments generated $2.4
billion of cash in the 10 years ended March 31.
Not only is Sun failing to offer a control premium, but it also
seemingly ignores Taro's 22 generic drugs awaiting clearance in the
U.S., including four with tentative approvals.
With a market value of $31
billion4, Sun can pay more. Sun is offering, net
of Taro's cash, $16 million for the
roughly 8.1 million Taro shares it doesn't own5.
Taro's actions suggest it agrees with our assessment. In
December 2019, Taro paid $91 a share to repurchase its stock in a tender
offer – nearly two-and-one-half times Sun's current bid.
Sun's tactics ring familiar. In October
2011, it lowballed Taro's shareholders with a $24.50-a-share bid. Ten months later, Sun raised
its offer more than 60% to $39.50
after a special committee of Taro directors rejected the bid.
Sun requires approval of the majority of Taro's minority
shareholders. Unless Sun acknowledges Taro's value, we refuse to
support the transaction.
Notes:
1Krensavage Asset Management's 641,910 shares of Taro
on March 31 make it Taro's No. 2
shareholder, according to Bloomberg.
2Tangible assets equal assets of $2.1 billion on March
31 minus goodwill of $17
million and liabilities of $405
million.
3Krensavage defines Taro's net cash as current assets
of $1.3 billion plus long-term
marketable securities of $405 million
minus current liabilities of $386
million.
4Bloomberg lists Sun's closing market cap on
July 13 as $31.4 billion.
5Taro had 37,584,631 shares outstanding as of
March 31. Sun controlled 29,497,813
shares of Taro according to Sun's May
26 13D/A.
Contact:
David W. Walbert
Senior Analyst
Krensavage Asset Management LLC
Office: (212) 706-0589
Info@krensavage.com
View original
content:https://www.prnewswire.com/news-releases/krensavage-asset-management-opposes-suns-lowball-bid-for-taro-301880370.html
SOURCE Krensavage Asset Management LLC
